The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya
Backgound: Sulphadoxine/sulphalene-pyrimethamine (SP) was adopted in Kenya as first line therapeutic for uncomplicated malaria in 1998. By the second half of 2003, there was convincing evidence that SP was failing and had to be replaced. Despite several descriptive investigations of policy change an...
Những tác giả chính: | Amin, A, Zurovac, D, Kangwana, B, Greeenfield, J, Otieno, D, Akhwale, W, Snow, R |
---|---|
Định dạng: | Journal article |
Ngôn ngữ: | English |
Được phát hành: |
BioMed Central
2007
|
Những chủ đề: |
Những quyển sách tương tự
-
The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya.
Bằng: Amin, A, et al.
Được phát hành: (2007) -
The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya
Bằng: Otieno Dorothy N, et al.
Được phát hành: (2007-05-01) -
The decline in paediatric malaria admissions on the coast of Kenya
Bằng: Okiro, E, et al.
Được phát hành: (2007) -
Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional study
Bằng: Zurovac, D, et al.
Được phát hành: (2007) -
Why don't health workers prescribe ACT? A qualitative study of factors affecting the prescription of artemether-lumefantrine
Bằng: Wasunna, B, et al.
Được phát hành: (2008)